ANXA5 M2 Haplotyping in IVF Patients and Embryos

Running, not enrolling

Conditions studied: Infertility, Miscarriage, Recurrent, Pregnancy Complications

In brief

This study aims to characterize the association between history of pregnancy complications and M2 carrier status in IVF patients and the utility of M2 haplotype preimplantation genetic testing (PGT) in embryos produced by carrier couples. Participants in this study will be screened for the M2 variant. History of pregnancy complications and miscarriages will be studied in order to determine potential associations with M2 carrier-ship.

Key facts

Study ID

NCT04544462

Run by

Genomic Prediction Inc.

People needed

500

Starts

2020-02-10

Expected to finish

2026-12-01

Last updated by the study team

2025-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All couples above the age of 18

You may not qualify if…

• Any case where biological parental DNA is unavailable.

Where it is running

• Genomic Prediction Clinical Laboratory — North Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.